Associated Papers
Clinical and Genetic Analysis of SMARCC2-Related Diseases in Three Chinese Patients.
Ou S et al.
Molecular Genetics & Genomic Medicine, 2026
41532374 (PubMed )
Supplement: MGG3-14-e70198-s001.xlsx › Table_S1
Long-read sequencing identifies a novel de novo inversion in SMARCC2 in a pediatric patient with Coffin-siris syndrome 8: a case report.
Ibrahim AA et al.
Bmc Medical Genomics, 2025
O-GlcNAc transferase congenital disorder of glycosylation (OGT-CDG): Potential mechanistic targets revealed by evaluating the OGT interactome.
Mayfield JM et al.
The Journal of Biological Chemistry, 2024
Elucidating the clinical and molecular spectrum of SMARCC2-associated NDD in a cohort of 65 affected individuals.
Bosch E et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics, 2023
De Novo SMARCC2 Variant in a Chinese Woman with Coffin-Siris Syndrome 8: a Case Report with Mild Intellectual Disability and Endocrinopathy.
Yi S et al.
Journal of Molecular Neuroscience : Mn, 2022
Further supporting SMARCC2-related neurodevelopmental disorder through exome analysis and reanalysis in two patients.
Li D et al.
American Journal of Medical Genetics. Part A, 2022
Expanding the Spectrum of BAF-Related Disorders: De Novo Variants in SMARCC2 Cause a Syndrome with Intellectual Disability and Developmental Delay.
Machol K et al.
American Journal of Human Genetics, 2019
Select a paper to view details